{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:38:06Z","timestamp":1789133886663,"version":"build-2803163510"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Reprod Sci"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/0974-1208.147492","type":"journal-article","created":{"date-parts":[[2014,12,22]],"date-time":"2014-12-22T00:42:29Z","timestamp":1419208949000},"page":"255","source":"Crossref","is-referenced-by-count":53,"title":["Orlistat in polycystic ovarian syndrome reduces weight with improvement in lipid profile and pregnancy rates"],"prefix":"10.4103","volume":"7","author":[{"given":"Pratap","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-1208.147492-1","first-page":"14","volume-title":"Consensus on women\u2032s health aspects of polycystic ovary syndrome (PCOS)","author":"Amsterdam","year":"2012","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.147492-2","first-page":"1358","volume-title":"Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome","author":"Yildirim","year":"2003","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.147492-3","first-page":"213","volume-title":"Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases","author":"Kiddy","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/0974-1208.147492-4","first-page":"1966","volume-title":"Treatment of obesity in polycystic ovary syndrome: A position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","author":"Moran","year":"2009","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.147492-5","first-page":"966","volume-title":"An RCT of metformin versus orlistat for the management of obese anovulatory women","author":"Metwally","year":"2009","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.147492-6","first-page":"591","volume-title":"The effects of metformin or orlistat on obese women with polycystic ovary syndrome: A prospective randomized open-label study","author":"Ghandi","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"key-10.4103\/0974-1208.147492-7","first-page":"729","volume-title":"Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome","author":"Jayagopal","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.147492-8","first-page":"1294","volume-title":"Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups","author":"Misra","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"key-10.4103\/0974-1208.147492-9","first-page":"235","volume-title":"WHO reassesses appropriate body-mass index for Asian populations","author":"Choo","year":"2002","journal-title":"Lancet"},{"key":"key-10.4103\/0974-1208.147492-10","first-page":"157","volume-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","author":"WHO","year":"2004","journal-title":"Lancet"},{"key":"key-10.4103\/0974-1208.147492-11","first-page":"559","volume-title":"Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome","author":"Koiou","year":"2013","journal-title":"Hormones (Athens)"},{"key":"key-10.4103\/0974-1208.147492-12","first-page":"432","volume-title":"The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome","author":"Panidis","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/0974-1208.147492-13","first-page":"583","volume-title":"Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: Impact on metabolism and fertility","author":"Panidis","year":"2013","journal-title":"Endocrine"},{"key":"key-10.4103\/0974-1208.147492-14","first-page":"242","volume-title":"Diet, physical exercise and Orlistat administration increase serum anti-M\u00fcllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)","author":"Vosnakis","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"key-10.4103\/0974-1208.147492-15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000341824","volume-title":"Infertility treatment in polycystic ovary syndrome: Lifestyle interventions, medications and surgery","author":"Panidis","year":"2013","journal-title":"Front Horm Res"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:28:57Z","timestamp":1786649337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-1208.147492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"alternative-id":["147492"],"URL":"https:\/\/doi.org\/10.4103\/0974-1208.147492","relation":{},"ISSN":["0974-1208"],"issn-type":[{"value":"0974-1208","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}